Target intelligence / Profile preview

Cellular membranes and cell surface glycans

Molecular classification
Lipid, Carbohydrate, Glycoprotein, Glycolipid, Other
01

Overview

Cellular membranes and their associated carbohydrate moieties, including glycoproteins and glycolipids, form the essential boundary and interface of all living cells (Varki et al., Essentials of Glycobiology, 2017). The plasma membrane provides structural integrity and regulates the transport of molecules, while the glycocalyx—the carbohydrate-rich outer layer—plays a critical role in cell-cell recognition, adhesion, and signaling (Gallagher et al., 2019). In many diseases, such as cancer, the glycosylation patterns on the cell surface are significantly altered, leading to the expression of tumor-associated carbohydrate antigens (TACAs) that can be targeted by monoclonal antibodies like Dinutuximab (Feizi, 1985; NIH/NCI). Additionally, many anti-infective agents, such as Amphotericin B and Polymyxins, function by disrupting the integrity of microbial membranes or by binding to specific cell surface components (StatPearls, 2023). Despite their importance, targeting these structures presents challenges due to the potential for off-target effects on healthy host cells and the complex, heterogeneous nature of glycan structures (Nature Reviews Drug Discovery, 2021).

Other names
GlycocalyxPlasma membraneCell surface carbohydratesSurface glycoproteins and glycolipidsCell surface glycans
02

Mechanism of action

Direct disruption of lipid bilayer integrity, formation of transmembrane pores leading to ion leakage, binding to specific carbohydrate epitopes to block pathogen entry, and targeting of tumor-associated glycolipids for immune-mediated destruction.

03

Biological functions

Signal transductionImmune responseCell adhesionBarrier functionCell-cell recognitionMolecular transport
04

Disease associations

InfectionCancerInflammationAutoimmune disease
05

Safety considerations

Non-specific membrane damage in host tissues (e.g., hemolysis)Nephrotoxicity and neurotoxicity associated with membrane-active antibioticsPotential for autoimmune cross-reactivity with host glycansHigh structural diversity making precise targeting difficult
06

Interacting drugs

Amphotericin B

6 more in the full profile.

07

Biomarkers

CA 19-9 (Carbohydrate Antigen 19-9)CA 125 (Mucin 16)GD2 expression levelsSialyl-Lewis X expression

Beyond the preview

Go deeper on Cellular membranes and cell surface glycans.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular membranes and cell surface glycans.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call